Picture of iTeos Therapeutics logo

ITOS — iTeos Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: iTeos Reports Q2 Loss Per Share Of $0.75

Aug 12 (Reuters) - iTeos Therapeutics Inc  ITOS.O :
    * ITEOS REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
    * Q2 LOSS PER SHARE $0.75
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.41 -- REFINITIV IBES
DATA
    * HAD CASH AND CASH EQUIVALENTS OF $302.9 MILLION AS OF JUNE
30,
2021, COMPARED TO $136.9 MILLION AS OF JUNE 30, 2020
    * ITEOS THERAPEUTICS - BELIEVES EXISTING CASH, CASH
EQUIVALENTS
WOULD ENABLE CO TO FUND OPERATING EXPENSES, CAPITAL EXPENDITURE
REQUIREMENTS INTO 2026

Source text for Eikon:  ID:nGNX6wsdh4 
Further company coverage:  ITOS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on iTeos Therapeutics

See all news